nodes	percent_of_prediction	percent_of_DWPC	metapath
Fexofenadine—ABCB1—Sorafenib—thyroid cancer	0.0487	0.32	CbGbCtD
Fexofenadine—CYP2D6—Sorafenib—thyroid cancer	0.0459	0.302	CbGbCtD
Fexofenadine—ABCB1—Doxorubicin—thyroid cancer	0.0296	0.194	CbGbCtD
Fexofenadine—CYP2D6—Doxorubicin—thyroid cancer	0.0279	0.183	CbGbCtD
Fexofenadine—Dry eye—Vandetanib—thyroid cancer	0.027	0.0319	CcSEcCtD
Fexofenadine—Rhinorrhoea—Sorafenib—thyroid cancer	0.0244	0.0288	CcSEcCtD
Fexofenadine—Atrial fibrillation—Vandetanib—thyroid cancer	0.0224	0.0265	CcSEcCtD
Fexofenadine—Nasopharyngitis—Vandetanib—thyroid cancer	0.019	0.0224	CcSEcCtD
Fexofenadine—Upper respiratory tract infection—Vandetanib—thyroid cancer	0.0171	0.0201	CcSEcCtD
Fexofenadine—Pollakiuria—Vandetanib—thyroid cancer	0.017	0.02	CcSEcCtD
Fexofenadine—Cardiac failure congestive—Sorafenib—thyroid cancer	0.0158	0.0186	CcSEcCtD
Fexofenadine—Epistaxis—Vandetanib—thyroid cancer	0.0154	0.0182	CcSEcCtD
Fexofenadine—Sinusitis—Vandetanib—thyroid cancer	0.0154	0.0181	CcSEcCtD
Fexofenadine—Pain in extremity—Sorafenib—thyroid cancer	0.0143	0.0169	CcSEcCtD
Fexofenadine—Nasopharyngitis—Sorafenib—thyroid cancer	0.0128	0.0151	CcSEcCtD
Fexofenadine—Vision blurred—Vandetanib—thyroid cancer	0.0121	0.0142	CcSEcCtD
Fexofenadine—Abdominal discomfort—Sorafenib—thyroid cancer	0.0119	0.014	CcSEcCtD
Fexofenadine—Cough—Vandetanib—thyroid cancer	0.0112	0.0132	CcSEcCtD
Fexofenadine—Dry mouth—Vandetanib—thyroid cancer	0.0107	0.0126	CcSEcCtD
Fexofenadine—Epistaxis—Sorafenib—thyroid cancer	0.0104	0.0123	CcSEcCtD
Fexofenadine—Infection—Vandetanib—thyroid cancer	0.0104	0.0122	CcSEcCtD
Fexofenadine—Musculoskeletal discomfort—Vandetanib—thyroid cancer	0.00952	0.0112	CcSEcCtD
Fexofenadine—Insomnia—Vandetanib—thyroid cancer	0.00945	0.0111	CcSEcCtD
Fexofenadine—Otitis media—Epirubicin—thyroid cancer	0.00938	0.0111	CcSEcCtD
Fexofenadine—Dyspnoea—Vandetanib—thyroid cancer	0.00931	0.011	CcSEcCtD
Fexofenadine—Flushing—Sorafenib—thyroid cancer	0.0092	0.0109	CcSEcCtD
Fexofenadine—Dyspepsia—Vandetanib—thyroid cancer	0.0092	0.0108	CcSEcCtD
Fexofenadine—Fatigue—Vandetanib—thyroid cancer	0.00901	0.0106	CcSEcCtD
Fexofenadine—Pain—Vandetanib—thyroid cancer	0.00893	0.0105	CcSEcCtD
Fexofenadine—Otitis media—Doxorubicin—thyroid cancer	0.00867	0.0102	CcSEcCtD
Fexofenadine—Gastrointestinal pain—Vandetanib—thyroid cancer	0.00854	0.0101	CcSEcCtD
Fexofenadine—Body temperature increased—Vandetanib—thyroid cancer	0.00826	0.00974	CcSEcCtD
Fexofenadine—Abdominal pain—Vandetanib—thyroid cancer	0.00826	0.00974	CcSEcCtD
Fexofenadine—Viral infection—Epirubicin—thyroid cancer	0.00808	0.00953	CcSEcCtD
Fexofenadine—Angioedema—Sorafenib—thyroid cancer	0.00789	0.0093	CcSEcCtD
Fexofenadine—Cough—Sorafenib—thyroid cancer	0.00753	0.00889	CcSEcCtD
Fexofenadine—Asthenia—Vandetanib—thyroid cancer	0.00749	0.00884	CcSEcCtD
Fexofenadine—Viral infection—Doxorubicin—thyroid cancer	0.00748	0.00882	CcSEcCtD
Fexofenadine—Pruritus—Vandetanib—thyroid cancer	0.00739	0.00872	CcSEcCtD
Fexofenadine—Myalgia—Sorafenib—thyroid cancer	0.00735	0.00867	CcSEcCtD
Fexofenadine—Dry mouth—Sorafenib—thyroid cancer	0.00719	0.00848	CcSEcCtD
Fexofenadine—Diarrhoea—Vandetanib—thyroid cancer	0.00715	0.00843	CcSEcCtD
Fexofenadine—Anaphylactic shock—Sorafenib—thyroid cancer	0.00705	0.00831	CcSEcCtD
Fexofenadine—Infection—Sorafenib—thyroid cancer	0.007	0.00826	CcSEcCtD
Fexofenadine—Dizziness—Vandetanib—thyroid cancer	0.00691	0.00815	CcSEcCtD
Fexofenadine—Dry eye—Epirubicin—thyroid cancer	0.00674	0.00795	CcSEcCtD
Fexofenadine—Vomiting—Vandetanib—thyroid cancer	0.00664	0.00783	CcSEcCtD
Fexofenadine—Rash—Vandetanib—thyroid cancer	0.00659	0.00777	CcSEcCtD
Fexofenadine—Dermatitis—Vandetanib—thyroid cancer	0.00658	0.00776	CcSEcCtD
Fexofenadine—Headache—Vandetanib—thyroid cancer	0.00654	0.00772	CcSEcCtD
Fexofenadine—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.00642	0.00757	CcSEcCtD
Fexofenadine—Dyspnoea—Sorafenib—thyroid cancer	0.00628	0.00741	CcSEcCtD
Fexofenadine—Dry eye—Doxorubicin—thyroid cancer	0.00624	0.00736	CcSEcCtD
Fexofenadine—Nausea—Vandetanib—thyroid cancer	0.0062	0.00732	CcSEcCtD
Fexofenadine—Dyspepsia—Sorafenib—thyroid cancer	0.0062	0.00732	CcSEcCtD
Fexofenadine—Fatigue—Sorafenib—thyroid cancer	0.00608	0.00716	CcSEcCtD
Fexofenadine—Pain—Sorafenib—thyroid cancer	0.00603	0.00711	CcSEcCtD
Fexofenadine—Cardiac failure congestive—Epirubicin—thyroid cancer	0.00584	0.00689	CcSEcCtD
Fexofenadine—Gastrointestinal pain—Sorafenib—thyroid cancer	0.00576	0.0068	CcSEcCtD
Fexofenadine—Increased appetite—Epirubicin—thyroid cancer	0.00564	0.00665	CcSEcCtD
Fexofenadine—Urticaria—Sorafenib—thyroid cancer	0.0056	0.0066	CcSEcCtD
Fexofenadine—Abdominal pain—Sorafenib—thyroid cancer	0.00557	0.00657	CcSEcCtD
Fexofenadine—Body temperature increased—Sorafenib—thyroid cancer	0.00557	0.00657	CcSEcCtD
Fexofenadine—Cardiac failure congestive—Doxorubicin—thyroid cancer	0.00541	0.00638	CcSEcCtD
Fexofenadine—Pain in extremity—Epirubicin—thyroid cancer	0.0053	0.00625	CcSEcCtD
Fexofenadine—Increased appetite—Doxorubicin—thyroid cancer	0.00522	0.00615	CcSEcCtD
Fexofenadine—Hypersensitivity—Sorafenib—thyroid cancer	0.00519	0.00612	CcSEcCtD
Fexofenadine—Asthenia—Sorafenib—thyroid cancer	0.00506	0.00596	CcSEcCtD
Fexofenadine—Pruritus—Sorafenib—thyroid cancer	0.00499	0.00588	CcSEcCtD
Fexofenadine—Pain in extremity—Doxorubicin—thyroid cancer	0.0049	0.00578	CcSEcCtD
Fexofenadine—Diarrhoea—Sorafenib—thyroid cancer	0.00482	0.00569	CcSEcCtD
Fexofenadine—Nasopharyngitis—Epirubicin—thyroid cancer	0.00474	0.00559	CcSEcCtD
Fexofenadine—Dizziness—Sorafenib—thyroid cancer	0.00466	0.0055	CcSEcCtD
Fexofenadine—Vomiting—Sorafenib—thyroid cancer	0.00448	0.00528	CcSEcCtD
Fexofenadine—Rash—Sorafenib—thyroid cancer	0.00444	0.00524	CcSEcCtD
Fexofenadine—Dermatitis—Sorafenib—thyroid cancer	0.00444	0.00524	CcSEcCtD
Fexofenadine—Headache—Sorafenib—thyroid cancer	0.00441	0.00521	CcSEcCtD
Fexofenadine—Nasopharyngitis—Doxorubicin—thyroid cancer	0.00438	0.00517	CcSEcCtD
Fexofenadine—Upper respiratory tract infection—Epirubicin—thyroid cancer	0.00426	0.00502	CcSEcCtD
Fexofenadine—Pollakiuria—Epirubicin—thyroid cancer	0.00423	0.00499	CcSEcCtD
Fexofenadine—Nausea—Sorafenib—thyroid cancer	0.00419	0.00494	CcSEcCtD
Fexofenadine—Drowsiness—Epirubicin—thyroid cancer	0.00408	0.00482	CcSEcCtD
Fexofenadine—Upper respiratory tract infection—Doxorubicin—thyroid cancer	0.00394	0.00464	CcSEcCtD
Fexofenadine—Pollakiuria—Doxorubicin—thyroid cancer	0.00391	0.00462	CcSEcCtD
Fexofenadine—Epistaxis—Epirubicin—thyroid cancer	0.00385	0.00454	CcSEcCtD
Fexofenadine—Sinusitis—Epirubicin—thyroid cancer	0.00383	0.00452	CcSEcCtD
Fexofenadine—Drowsiness—Doxorubicin—thyroid cancer	0.00378	0.00446	CcSEcCtD
Fexofenadine—Epistaxis—Doxorubicin—thyroid cancer	0.00356	0.0042	CcSEcCtD
Fexofenadine—Sinusitis—Doxorubicin—thyroid cancer	0.00354	0.00418	CcSEcCtD
Fexofenadine—Flushing—Epirubicin—thyroid cancer	0.0034	0.00401	CcSEcCtD
Fexofenadine—Flushing—Doxorubicin—thyroid cancer	0.00315	0.00371	CcSEcCtD
Fexofenadine—Flatulence—Epirubicin—thyroid cancer	0.00314	0.00371	CcSEcCtD
Fexofenadine—Tension—Epirubicin—thyroid cancer	0.00313	0.00369	CcSEcCtD
Fexofenadine—Nervousness—Epirubicin—thyroid cancer	0.0031	0.00366	CcSEcCtD
Fexofenadine—Back pain—Epirubicin—thyroid cancer	0.00309	0.00364	CcSEcCtD
Fexofenadine—Vision blurred—Epirubicin—thyroid cancer	0.00301	0.00355	CcSEcCtD
Fexofenadine—Agitation—Epirubicin—thyroid cancer	0.00293	0.00346	CcSEcCtD
Fexofenadine—Flatulence—Doxorubicin—thyroid cancer	0.00291	0.00343	CcSEcCtD
Fexofenadine—Tension—Doxorubicin—thyroid cancer	0.0029	0.00342	CcSEcCtD
Fexofenadine—Nervousness—Doxorubicin—thyroid cancer	0.00287	0.00338	CcSEcCtD
Fexofenadine—Back pain—Doxorubicin—thyroid cancer	0.00286	0.00337	CcSEcCtD
Fexofenadine—Palpitations—Epirubicin—thyroid cancer	0.00282	0.00333	CcSEcCtD
Fexofenadine—Cough—Epirubicin—thyroid cancer	0.00278	0.00328	CcSEcCtD
Fexofenadine—Vision blurred—Doxorubicin—thyroid cancer	0.00278	0.00328	CcSEcCtD
Fexofenadine—Myalgia—Epirubicin—thyroid cancer	0.00272	0.0032	CcSEcCtD
Fexofenadine—Agitation—Doxorubicin—thyroid cancer	0.00271	0.0032	CcSEcCtD
Fexofenadine—Dry mouth—Epirubicin—thyroid cancer	0.00266	0.00313	CcSEcCtD
Fexofenadine—Palpitations—Doxorubicin—thyroid cancer	0.00261	0.00308	CcSEcCtD
Fexofenadine—Anaphylactic shock—Epirubicin—thyroid cancer	0.0026	0.00307	CcSEcCtD
Fexofenadine—Infection—Epirubicin—thyroid cancer	0.00259	0.00305	CcSEcCtD
Fexofenadine—Cough—Doxorubicin—thyroid cancer	0.00258	0.00304	CcSEcCtD
Fexofenadine—Tachycardia—Epirubicin—thyroid cancer	0.00254	0.003	CcSEcCtD
Fexofenadine—Myalgia—Doxorubicin—thyroid cancer	0.00251	0.00296	CcSEcCtD
Fexofenadine—Dry mouth—Doxorubicin—thyroid cancer	0.00246	0.0029	CcSEcCtD
Fexofenadine—Anaphylactic shock—Doxorubicin—thyroid cancer	0.00241	0.00284	CcSEcCtD
Fexofenadine—Infection—Doxorubicin—thyroid cancer	0.00239	0.00282	CcSEcCtD
Fexofenadine—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.00237	0.0028	CcSEcCtD
Fexofenadine—Insomnia—Epirubicin—thyroid cancer	0.00236	0.00278	CcSEcCtD
Fexofenadine—Tachycardia—Doxorubicin—thyroid cancer	0.00235	0.00277	CcSEcCtD
Fexofenadine—Dyspnoea—Epirubicin—thyroid cancer	0.00232	0.00274	CcSEcCtD
Fexofenadine—Somnolence—Epirubicin—thyroid cancer	0.00232	0.00273	CcSEcCtD
Fexofenadine—Dyspepsia—Epirubicin—thyroid cancer	0.00229	0.0027	CcSEcCtD
Fexofenadine—Fatigue—Epirubicin—thyroid cancer	0.00225	0.00265	CcSEcCtD
Fexofenadine—Pain—Epirubicin—thyroid cancer	0.00223	0.00263	CcSEcCtD
Fexofenadine—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.0022	0.00259	CcSEcCtD
Fexofenadine—Insomnia—Doxorubicin—thyroid cancer	0.00218	0.00257	CcSEcCtD
Fexofenadine—Dyspnoea—Doxorubicin—thyroid cancer	0.00215	0.00253	CcSEcCtD
Fexofenadine—Somnolence—Doxorubicin—thyroid cancer	0.00214	0.00253	CcSEcCtD
Fexofenadine—Gastrointestinal pain—Epirubicin—thyroid cancer	0.00213	0.00251	CcSEcCtD
Fexofenadine—Dyspepsia—Doxorubicin—thyroid cancer	0.00212	0.0025	CcSEcCtD
Fexofenadine—Fatigue—Doxorubicin—thyroid cancer	0.00208	0.00245	CcSEcCtD
Fexofenadine—Urticaria—Epirubicin—thyroid cancer	0.00207	0.00244	CcSEcCtD
Fexofenadine—Pain—Doxorubicin—thyroid cancer	0.00206	0.00243	CcSEcCtD
Fexofenadine—Body temperature increased—Epirubicin—thyroid cancer	0.00206	0.00243	CcSEcCtD
Fexofenadine—Abdominal pain—Epirubicin—thyroid cancer	0.00206	0.00243	CcSEcCtD
Fexofenadine—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.00197	0.00232	CcSEcCtD
Fexofenadine—Hypersensitivity—Epirubicin—thyroid cancer	0.00192	0.00226	CcSEcCtD
Fexofenadine—Urticaria—Doxorubicin—thyroid cancer	0.00191	0.00226	CcSEcCtD
Fexofenadine—Body temperature increased—Doxorubicin—thyroid cancer	0.0019	0.00225	CcSEcCtD
Fexofenadine—Abdominal pain—Doxorubicin—thyroid cancer	0.0019	0.00225	CcSEcCtD
Fexofenadine—Asthenia—Epirubicin—thyroid cancer	0.00187	0.0022	CcSEcCtD
Fexofenadine—Pruritus—Epirubicin—thyroid cancer	0.00184	0.00217	CcSEcCtD
Fexofenadine—Diarrhoea—Epirubicin—thyroid cancer	0.00178	0.0021	CcSEcCtD
Fexofenadine—Hypersensitivity—Doxorubicin—thyroid cancer	0.00178	0.00209	CcSEcCtD
Fexofenadine—Asthenia—Doxorubicin—thyroid cancer	0.00173	0.00204	CcSEcCtD
Fexofenadine—Dizziness—Epirubicin—thyroid cancer	0.00172	0.00203	CcSEcCtD
Fexofenadine—Pruritus—Doxorubicin—thyroid cancer	0.0017	0.00201	CcSEcCtD
Fexofenadine—Vomiting—Epirubicin—thyroid cancer	0.00166	0.00195	CcSEcCtD
Fexofenadine—Diarrhoea—Doxorubicin—thyroid cancer	0.00165	0.00194	CcSEcCtD
Fexofenadine—Rash—Epirubicin—thyroid cancer	0.00164	0.00194	CcSEcCtD
Fexofenadine—Dermatitis—Epirubicin—thyroid cancer	0.00164	0.00193	CcSEcCtD
Fexofenadine—Headache—Epirubicin—thyroid cancer	0.00163	0.00192	CcSEcCtD
Fexofenadine—Dizziness—Doxorubicin—thyroid cancer	0.00159	0.00188	CcSEcCtD
Fexofenadine—Nausea—Epirubicin—thyroid cancer	0.00155	0.00182	CcSEcCtD
Fexofenadine—Vomiting—Doxorubicin—thyroid cancer	0.00153	0.00181	CcSEcCtD
Fexofenadine—Rash—Doxorubicin—thyroid cancer	0.00152	0.00179	CcSEcCtD
Fexofenadine—Dermatitis—Doxorubicin—thyroid cancer	0.00152	0.00179	CcSEcCtD
Fexofenadine—Headache—Doxorubicin—thyroid cancer	0.00151	0.00178	CcSEcCtD
Fexofenadine—Nausea—Doxorubicin—thyroid cancer	0.00143	0.00169	CcSEcCtD
